title: Depo Provera and breast cancer.
authors.forename: L
authors.initials: L
authors.lastname: McCowan
authors.forename: C
authors.initials: C
authors.lastname: Farquhar
authors.forename: C
authors.initials: C
authors.lastname: Roke
authors.forename: H
authors.initials: H
authors.lastname: Liddell
authors.forename: H
authors.initials: H
authors.lastname: Roberts
authors.forename: N
authors.initials: N
authors.lastname: Thakurdas
authors.forename: J
authors.initials: J
authors.lastname: Wilson
authors.forename: P J
authors.initials: PJ
authors.lastname: Say
authors.forename: F
authors.initials: F
authors.lastname: McClure
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000139:chemically induced*; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects / Q000031:analogs & derivatives*; D017258:Medroxyprogesterone Acetate; D012306:Risk
chemical_list: D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone